Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1864 1
1890 3
1898 1
1947 3
1949 1
1950 2
1956 1
1960 1
1961 1
1986 1
1988 1
1989 1
1991 1
1994 1
1999 1
2000 1
2001 1
2002 1
2003 2
2004 6
2005 3
2006 1
2007 6
2008 6
2009 8
2010 9
2011 16
2012 11
2013 3
2014 6
2015 6
2016 6
2017 9
2018 3
2020 3
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 25568217

115 results
Results by year
Filters applied: . Clear all
Page 1
Number and frequency of albuminuria measurements in clinical trials in diabetic nephropathy.
Kröpelin TF, de Zeeuw D, Andress DL, Bijlsma MJ, Persson F, Parving HH, Heerspink HJ. Kröpelin TF, et al. Clin J Am Soc Nephrol. 2015 Mar 6;10(3):410-6. doi: 10.2215/CJN.07780814. Epub 2015 Jan 7. Clin J Am Soc Nephrol. 2015. PMID: 25568217 Free PMC article.
Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.
de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, Snapinn S, Cooper ME, Mitch WE, Brenner BM. de Zeeuw D, et al. Kidney Int. 2004 Jun;65(6):2309-20. doi: 10.1111/j.1523-1755.2004.00653.x. Kidney Int. 2004. PMID: 15149345 Free article. Clinical Trial.
The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy.
de Zeeuw D, Coll B, Andress D, Brennan JJ, Tang H, Houser M, Correa-Rotter R, Kohan D, Lambers Heerspink HJ, Makino H, Perkovic V, Pritchett Y, Remuzzi G, Tobe SW, Toto R, Viberti G, Parving HH. de Zeeuw D, et al. J Am Soc Nephrol. 2014 May;25(5):1083-93. doi: 10.1681/ASN.2013080830. Epub 2014 Apr 10. J Am Soc Nephrol. 2014. PMID: 24722445 Free PMC article. Clinical Trial.
Aliskiren in combination with losartan reduces albuminuria independent of baseline blood pressure in patients with type 2 diabetes and nephropathy.
Persson F, Lewis JB, Lewis EJ, Rossing P, Hollenberg NK, Parving HH. Persson F, et al. Clin J Am Soc Nephrol. 2011 May;6(5):1025-31. doi: 10.2215/CJN.07590810. Epub 2011 Feb 24. Clin J Am Soc Nephrol. 2011. PMID: 21350110 Free PMC article. Clinical Trial.
Determining the Optimal Protocol for Measuring an Albuminuria Class Transition in Clinical Trials in Diabetic Kidney Disease.
Kröpelin TF, de Zeeuw D, Remuzzi G, Bilous R, Parving HH, Heerspink HJ. Kröpelin TF, et al. J Am Soc Nephrol. 2016 Nov;27(11):3405-3412. doi: 10.1681/ASN.2015101150. Epub 2016 Apr 7. J Am Soc Nephrol. 2016. PMID: 27056294 Free PMC article.
Time course of the antiproteinuric and antihypertensive effect of losartan in diabetic nephropathy.
Andersen S, Jacobsen P, Tarnow L, Rossing P, Juhl TR, Parving HH. Andersen S, et al. Nephrol Dial Transplant. 2003 Feb;18(2):293-7. doi: 10.1093/ndt/18.2.293. Nephrol Dial Transplant. 2003. PMID: 12543883
Paricalcitol for reduction of albuminuria in diabetes.
Kassimatis T. Kassimatis T. Lancet. 2011 Feb 19;377(9766):635, author reply 636-7. doi: 10.1016/S0140-6736(11)60223-7. Lancet. 2011. PMID: 21334524 No abstract available.
Predictors of Atrasentan-Associated Fluid Retention and Change in Albuminuria in Patients with Diabetic Nephropathy.
Kohan DE, Lambers Heerspink HJ, Coll B, Andress D, Brennan JJ, Kitzman DW, Correa-Rotter R, Makino H, Perkovic V, Hou FF, Remuzzi G, Tobe SW, Toto R, Parving HH, de Zeeuw D. Kohan DE, et al. Clin J Am Soc Nephrol. 2015 Sep 4;10(9):1568-74. doi: 10.2215/CJN.00570115. Epub 2015 Jul 7. Clin J Am Soc Nephrol. 2015. PMID: 26153128 Free PMC article. Clinical Trial.
Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy.
de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, Snapinn S, Cooper ME, Mitch WE, Brenner BM. de Zeeuw D, et al. Circulation. 2004 Aug 24;110(8):921-7. doi: 10.1161/01.CIR.0000139860.33974.28. Epub 2004 Aug 9. Circulation. 2004. PMID: 15302780 Clinical Trial.
Angiotensin receptor blocker and N-acetyl cysteine for reduction of proteinuria in patients with type 2 diabetes mellitus.
Rasi Hashemi S, Noshad H, Tabrizi A, Mobasseri M, Tayebi Khosroshahi H, Heydarnejad M, Khalaj MR, Aghamohammadzadeh N. Rasi Hashemi S, et al. Iran J Kidney Dis. 2012 Jan;6(1):39-43. Iran J Kidney Dis. 2012. PMID: 22218118 Free article. Clinical Trial.
115 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback